Key result
Black individuals carrying risk alleles from both LSD1 and STRN had significantly higher salt-sensitive blood pressure than lower-risk individuals (18.9 vs 10.8 mm Hg; P<.0001).
Why the study?
Risk alleles in LSD1 and STRN independently associate with salt-sensitive blood pressure, but whether Black vs White carriers of risk alleles in both genes have more severe salt sensitivity was unverified.
Does carrying risk alleles in both LSD1 and STRN increase salt-sensitive blood pressure in Black individuals?
Cohort (n=560)
Does carrying risk alleles in both LSD1 and STRN increase salt-sensitive blood pressure in Black individuals?
Black individuals carrying risk alleles in both LSD1 and STRN exhibit significantly greater salt-sensitive blood pressure, suggesting a potential targeted role for mineralocorticoid receptor blockade in this population.
Should not yet change practice; leaves open genotype-guided MR-blockade trials in dual-risk Black patients with salt-sensitive hypertension.
BACKGROUND: Risk alleles in lysine-specific demethylase 1 (LSD1) and striatin (STRN) are independently associated with greater salt-sensitive blood pressure (SSBP) and increased aldosterone and/or mineralocorticoid receptor (MR) activity. We tested the hypothesis that Black, but not White, risk allele carriers in both genes would have a more severe degree of SSBP than those carrying a single risk allele from either gene alone. METHODS: Individuals from the HyperPATH cohort were assessed for blood pressure and hormone levels after controlled low- and liberal-sodium diets. Black and White individuals with genotype data for LSD1 (rs587168) and STRN diplotype (rs888083 and rs6744560) were included. RESULTS: A total of 127 Black individuals were categorized: (1) higher risk: individuals who carried 1 or 2 risk alleles from both LSD1 and STRN and (2) lower risk: individuals who did not meet these criteria. In multivariable analysis, SSBP was higher among the higher risk vs the lower risk groups (18.9 ± 1.8 mm Hg vs 10.8 ± 1.6 mm Hg, P < .0001). Among hypertensive individuals, SSBP was 22.9 ± 2.5 mm Hg vs 12.9 ± 2.1 mm Hg for the higher risk vs lower risk groups, respectively (P < .0001). These results were confirmed in a second cohort of 37 Black individuals (P = .029). In 396 White individuals, no differences were observed. CONCLUSION: Black, but not White, individuals with risk alleles from both LSD1 and STRN (44% of subjects) exhibited a higher degree of SSBP. In light of the MR-related drivers of SSBP in this population, MR blockade may be particularly effective.
No takes yet. Share an insight, caveat, or question.
Haas et al. (2025) conducted a cohort in Salt-sensitive blood pressure (n=560). Carrying 1 or 2 risk alleles from both LSD1 and STRN (higher risk) vs. Lower risk (not carrying risk alleles from both genes) was evaluated on Salt-sensitive blood pressure (SSBP) (p=<.0001). Black individuals carrying risk alleles from both LSD1 and STRN had significantly higher salt-sensitive blood pressure than lower-risk individuals (18.9 vs 10.8 mm Hg; P<.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: